Posted by Michael Wonder on 05 Aug 2015
The drug combination of ledipasvir and sofosbuvir (trade name Harvoni) has been available since November 2014 for the treatment of ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The European Medicines Agency (EMA) receives comprehensive clinical study data from drug manufacturers. These data form the basis for the ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
15 Juen 2015 - Since February 2015, aflibercept (trade name Eylea) has been available also for patients with impaired vision ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Since 2014 dulaglutide has been approved alone or in combination with other drugs for the treatment of adults with type ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
IQWiG has announced that it has commenced its assessment of the following medicines: ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The Institute for Quality and Efficiency in Health Care (IQWiG) investigated in a dossier assessment whether propranolol offers an added ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\P \e \r \t \u \z \u \m \a \b \space \( \P \e \r \j \e \t \a \) \ \w \a \s \space \l \a \u \n \c \h \e \d \space \i \n \space \G \e \r \m \a \n \y \space \i \n \ \M \a \r \c \h \space \2 \0 \1 \3 \space \f \o \r \space \u \s \e \ \a \s \space \a \d \j \u \n \c \t \i \v \e \space \t \h \e \r \a \p \y \space \b \y \space \c \e \r \t \a \i \n \space \p \a \t \i \e \n \t \s \space \w \i \t \h \space \a \d \v \a \n \c \e \d \ \H \E \R \2 \- \p \o \s \i \t \i \v \e \space \b \r \e \a \s \t \space \c \a \n \c \e \r \. \ " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\T \e \r \i \f \l \u \n \o \m \i \d \e \space \( \A \u \b \a \g \i \o \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \i \n \space \G \e \r \m \a \n \y \space \s \i \n \c \e \space \A \u \g \u \s \t \space \2 \0 \1 \3 \space \f \o \r \space \a \d \u \l \t \s \space \w \i \t \h \space \r \e \l \a \p \s \i \n \g \space \r \e \m \i \t \t \i \n \g \space \m \u \l \t \i \p \l \e \space \s \c \l \e \r \o \s \i \s \. \space \I \n \space \a \n \space \e \a \r \l \y " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
Danish drugmaker Novo Nordisk, the world's biggest insulin producer, said on Wednesday it had decided to launch its diabetes drug ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Since September 2014, the fixed-dose combination of dolutegravir/abacavir/lamivudine (trade name Triumeq) has been approved for human immunodeficiency virus (HIV) infected ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Four years have passed since the introduction of the German Act on the Reform of the Market for Medicinal Products ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The European Commission on Friday cleared a German scheme that allowed exceptions to be made for pharmaceutical groups whose medicines ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Canagliflozin (Invokana) has been approved since November 2013 for use as monotherapy and in various combination therapies for adults with type 2 iabetes mellitus, ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or ...
Read more →